Cargando…

Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis

Detalles Bibliográficos
Autores principales:	Edo, Ángel, Espinosa-Parrilla, Juan Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696835/ https://www.ncbi.nlm.nih.gov/pubmed/29171419 http://dx.doi.org/10.4103/1673-5374.217327

Ejemplares similares

Ocular Gene Therapy with Adeno-associated Virus Vectors: Current Outlook for Patients and Researchers
por: Casey, Geoffrey A., et al.
Publicado: (2020)

Small scale adeno-associated virus-vector production for preclinical gene delivery based on chloroform precipitation
por: Davidsson, Marcus, et al.
Publicado: (2021)

Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis
por: Skundric, Dusanka S.
Publicado: (2015)

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
por: Miralles, Marta, et al.
Publicado: (2017)

Perspectives on neuroreparative therapies for treating multiple sclerosis
por: Xiao, Junhua
Publicado: (2015)

Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist
por: Tsai, Ming-Ling, et al.
Publicado: (2009)

Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
por: Stoica, Lorelei, et al.
Publicado: (2016)

Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR
por: Meyer, Nancy L, et al.
Publicado: (2019)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis
por: Vilisaar, Janek, et al.
Publicado: (2015)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
por: D'Amico, Emanuele, et al.
Publicado: (2021)

The state of the art of adeno-associated virus-based vectors in gene therapy
por: Coura, Renata dos Santos, et al.
Publicado: (2007)

Ependymal cells and multiple sclerosis: proposing a relationship
por: Hatrock, Dale, et al.
Publicado: (2019)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

Adeno-Associated Viral Vectors in Neuroscience Research
por: Haggerty, David L., et al.
Publicado: (2019)

Ethical use of off-label disease-modifying therapies for multiple sclerosis
por: Laurson-Doube, Joanna, et al.
Publicado: (2021)

DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations
por: Schnödt, Maria, et al.
Publicado: (2016)

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis
por: Wu, Hao, et al.
Publicado: (2016)

Galectin-3 prospects as a therapeutic agent for multiple sclerosis
por: Thomas, Laura, et al.
Publicado: (2019)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
por: de Paula Faria, Daniele
Publicado: (2020)

The Importance of the Cognitive Aspects of Vocational Rehabilitation for Individuals With Multiple Sclerosis
por: Kennedy, Winston, et al.
Publicado: (2020)

Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
por: Ciolac, Dumitru, et al.
Publicado: (2022)

Trans-synaptic degeneration as a mechanism of neurodegeneration in multiple sclerosis
por: Murphy, Olwen C., et al.
Publicado: (2023)

IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
por: Maier, Lisa M., et al.
Publicado: (2009)

Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats
por: Li, Pengfei, et al.
Publicado: (2019)

Correction: The state of the art of adeno-associated virus-based vectors in gene therapy
por: dos Santos Coura, Renata, et al.
Publicado: (2010)

Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
por: Zhao, Liyuan, et al.
Publicado: (2023)

Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment
por: Silva, Berenice Anabel, et al.
Publicado: (2020)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

Novel Cytotoxic Vectors Based on Adeno-Associated Virus
por: Kohlschütter, Johannes, et al.
Publicado: (2010)

Production and Titering of Recombinant Adeno-associated Viral Vectors
por: McClure, Christina, et al.
Publicado: (2011)

Accurate Quantification and Characterization of Adeno-Associated Viral Vectors
por: Dobnik, David, et al.
Publicado: (2019)

Biochemical indicators for neuronal regeneration during intrathecal triamcinolone application in multiple sclerosis
por: Müller, Thomas, et al.
Publicado: (2015)

Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
por: De Kleijn, Kim M. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ikhadg5s5i00te315p94qssgs3